{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:47:47Z","timestamp":1782920867501,"version":"3.54.5"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A cluster of macrolide-resistant Mycoplasma pneumoniae -causing community-acquired pneumonia was observed in children in North Dakota in 2024. Suspicion was raised by non-response to macrolides, with confirmation via a polymerase-chain reaction assay. Prompt improvement occurred after the initiation of alternative antibiotics.<\/jats:p>","DOI":"10.1093\/jpids\/piae117","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:02:09Z","timestamp":1732204929000},"source":"Crossref","is-referenced-by-count":10,"title":["Macrolide-Resistant <i>Mycoplasma pneumoniae<\/i>, North Dakota 2024"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-7306","authenticated-orcid":false,"given":"Miltiadis","family":"Douvoyiannis","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Altru Health System , Grand Forks, North Dakota ,","place":["USA"]},{"name":"Department of Pediatric Infectious Diseases, Altru Health System , Grand Forks, North Dakota ,","place":["USA"]},{"name":"University of North Dakota , Grand Forks, School of Medicine, North Dakota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanner E","family":"Rothstein","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology - Clinical Microbiology,\u00a0Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-4141","authenticated-orcid":false,"given":"Robin","family":"Patel","sequence":"additional","affiliation":[{"name":"Divisions of Clinical Microbiology and Infectious Diseases , Mayo Clinic, Rochester, Minnesota , \u00a0","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"2025012114063566500_CIT0001","first-page":"834","article-title":"Mycoplasma pneumoniae respiratory illness\u2014two rural counties, West Virginia, 2011","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"Morb Mortal Wkly Rep"},{"key":"2025012114063566500_CIT0002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15585\/mmwr.mm7307a3","article-title":"Notes from the field: reemergence of Mycoplasma pneumoniae infections in children and adolescents after the COVID-19 pandemic, United States, 2018-2024","volume":"73","author":"Edens","year":"2024","journal-title":"Morb Mortal Wkly Rep"},{"key":"2025012114063566500_CIT0003","doi-asserted-by":"crossref","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","article-title":"Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and meta-analysis","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025012114063566500_CIT0004","doi-asserted-by":"crossref","first-page":"e0243221","DOI":"10.1128\/aac.02432-21","article-title":"Macrolide resistance in Mycoplasma pneumoniae, midwestern United States, 2014 to 2021","volume":"66","author":"Rothstein","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025012114063566500_CIT0005","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3201\/eid2706.203206","article-title":"Macrolide-resistant Mycoplasma pneumoniae infections in Children, Ohio, USA","volume":"27","author":"Lanata","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2025012114063566500_CIT0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025012114063566500_CIT0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0b013e318247f3e0","article-title":"Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States","volume":"31","author":"Yamada","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2025012114063566500_CIT0008","doi-asserted-by":"crossref","first-page":"e00968","DOI":"10.1128\/JCM.00968-19","article-title":"Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a National Surveillance Program","volume":"57","author":"Waites","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2025012114063566500_CIT0009","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3201\/eid2108.150273","article-title":"Macrolide-resistant Mycoplasma pneumoniae, United States","volume":"21","author":"Zheng","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2025012114063566500_CIT0010","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025012114063566500_CIT0011","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1086\/653535","article-title":"High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China","volume":"51","author":"Cao","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025012114063566500_CIT0012","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients","volume":"15","author":"Matsubara","year":"2009","journal-title":"J Infect Chemother"},{"key":"2025012114063566500_CIT0013","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1128\/JCM.02840-12","article-title":"Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children","volume":"51","author":"Cardinale","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2025012114063566500_CIT0014","doi-asserted-by":"crossref","first-page":"e0173635","DOI":"10.1371\/journal.pone.0173635","article-title":"Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufoxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"12","author":"Ishiguro","year":"2017","journal-title":"PLoS One"},{"key":"2025012114063566500_CIT0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s10156-012-0523-3","article-title":"Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan","volume":"19","author":"Wu","year":"2013","journal-title":"J Infect Chemother"},{"key":"2025012114063566500_CIT0016","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/antibiotics10020192","article-title":"Clinical efficacy of doxycycline for treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children","volume":"10","author":"Lee","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2025012114063566500_CIT0017","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","article-title":"Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis","volume":"21","author":"Ahn","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025012114063566500_CIT0018","doi-asserted-by":"crossref","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piae117\/60780292\/piae117.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/1\/piae117\/60780292\/piae117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/14\/1\/piae117\/60780292\/piae117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T14:06:46Z","timestamp":1737468406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piae117\/7906482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,20]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piae117","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,21]]},"article-number":"piae117"}}